GSK plc (GLAXF)
USD 16.84
(0.0%)
USD 16.84
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 5.49 Billion GBP | 6.84% |
| 2022 | 5.14 Billion GBP | -11.02% |
| 2021 | 5.78 Billion GBP | -3.55% |
| 2020 | 5.99 Billion GBP | 0.82% |
| 2019 | 5.94 Billion GBP | 8.6% |
| 2018 | 5.47 Billion GBP | -1.46% |
| 2017 | 5.55 Billion GBP | 8.92% |
| 2016 | 5.1 Billion GBP | 8.18% |
| 2015 | 4.71 Billion GBP | 11.46% |
| 2014 | 4.23 Billion GBP | 8.49% |
| 2013 | 3.9 Billion GBP | -1.74% |
| 2012 | 3.96 Billion GBP | 2.48% |
| 2011 | 3.87 Billion GBP | 0.94% |
| 2010 | 3.83 Billion GBP | -5.59% |
| 2009 | 4.06 Billion GBP | 0.2% |
| 2008 | 4.05 Billion GBP | 32.46% |
| 2007 | 3.06 Billion GBP | 25.65% |
| 2006 | 2.43 Billion GBP | 11.94% |
| 2005 | 2.17 Billion GBP | -0.73% |
| 2004 | 2.19 Billion GBP | 3.98% |
| 2003 | 2.1 Billion GBP | 1.39% |
| 2002 | 2.08 Billion GBP | -0.68% |
| 2001 | 2.09 Billion GBP | -8.02% |
| 2000 | 2.27 Billion GBP | 48.15% |
| 1999 | 1.53 Billion GBP | 33.19% |
| 1998 | 1.15 Billion GBP | 34.97% |
| 1997 | 855 Million GBP | 6.34% |
| 1996 | 804 Million GBP | -0.86% |
| 1995 | 811 Million GBP | 41.04% |
| 1994 | 575 Million GBP | -3.36% |
| 1993 | 595 Million GBP | 25.26% |
| 1992 | 475 Million GBP | -3.85% |
| 1991 | 494 Million GBP | 18.47% |
| 1990 | 417 Million GBP | 18.8% |
| 1989 | 351 Million GBP | 13.23% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 5.85 Billion GBP | 2.75% |
| 2024 Q1 | 5.7 Billion GBP | 3.71% |
| 2023 Q2 | 5.51 Billion GBP | 2.93% |
| 2023 Q3 | 5.48 Billion GBP | -0.58% |
| 2023 FY | 5.49 Billion GBP | 6.84% |
| 2023 Q1 | 5.35 Billion GBP | 4.06% |
| 2023 Q4 | 5.49 Billion GBP | 0.33% |
| 2022 Q4 | 5.14 Billion GBP | 10.45% |
| 2022 Q3 | 4.65 Billion GBP | -0.11% |
| 2022 Q2 | 4.66 Billion GBP | -22.31% |
| 2022 Q1 | 6 Billion GBP | 3.8% |
| 2022 FY | 5.14 Billion GBP | -11.02% |
| 2021 Q4 | 5.78 Billion GBP | -7.38% |
| 2021 FY | 5.78 Billion GBP | -3.55% |
| 2021 Q1 | 6.21 Billion GBP | 3.67% |
| 2021 Q2 | 6.33 Billion GBP | 1.83% |
| 2021 Q3 | 6.24 Billion GBP | -1.36% |
| 2020 Q2 | 6.39 Billion GBP | 7.46% |
| 2020 Q1 | 5.95 Billion GBP | 0.08% |
| 2020 FY | 5.99 Billion GBP | 0.82% |
| 2020 Q3 | 6.44 Billion GBP | 0.69% |
| 2020 Q4 | 5.99 Billion GBP | -6.89% |
| 2019 Q1 | 5.67 Billion GBP | 3.69% |
| 2019 Q2 | 5.95 Billion GBP | 4.95% |
| 2019 Q3 | 6.77 Billion GBP | 13.71% |
| 2019 Q4 | 5.94 Billion GBP | -12.23% |
| 2019 FY | 5.94 Billion GBP | 8.6% |
| 2018 FY | 5.47 Billion GBP | -1.46% |
| 2018 Q1 | 5.65 Billion GBP | 1.84% |
| 2018 Q3 | 5.78 Billion GBP | -2.61% |
| 2018 Q4 | 5.47 Billion GBP | -5.39% |
| 2018 Q2 | 5.94 Billion GBP | 5.02% |
| 2017 FY | 5.55 Billion GBP | 8.92% |
| 2017 Q3 | 5.66 Billion GBP | -1.43% |
| 2017 Q2 | 5.74 Billion GBP | 6.02% |
| 2017 Q4 | 5.55 Billion GBP | -1.84% |
| 2017 Q1 | 5.41 Billion GBP | 6.17% |
| 2016 FY | 5.1 Billion GBP | 8.18% |
| 2016 Q3 | 5.37 Billion GBP | -2.2% |
| 2016 Q2 | 5.49 Billion GBP | 6.93% |
| 2016 Q1 | 5.13 Billion GBP | 8.95% |
| 2016 Q4 | 5.1 Billion GBP | -5.04% |
| 2015 Q3 | 4.85 Billion GBP | 1.19% |
| 2015 Q1 | 4.57 Billion GBP | 8.2% |
| 2015 FY | 4.71 Billion GBP | 11.46% |
| 2015 Q2 | 4.79 Billion GBP | 4.78% |
| 2015 Q4 | 4.71 Billion GBP | -2.84% |
| 2014 Q1 | 4.09 Billion GBP | 4.95% |
| 2014 FY | 4.23 Billion GBP | 8.49% |
| 2014 Q2 | 4.11 Billion GBP | 0.44% |
| 2014 Q3 | 4.27 Billion GBP | 3.96% |
| 2014 Q4 | 4.23 Billion GBP | -1.01% |
| 2013 Q3 | 4.16 Billion GBP | 0.58% |
| 2013 FY | 3.9 Billion GBP | -1.74% |
| 2013 Q1 | 4.19 Billion GBP | 5.74% |
| 2013 Q4 | 3.9 Billion GBP | -6.41% |
| 2013 Q2 | 4.14 Billion GBP | -1.29% |
| 2012 FY | 3.96 Billion GBP | 2.48% |
| 2012 Q4 | 3.96 Billion GBP | -1.66% |
| 2012 Q3 | 4.03 Billion GBP | 1.94% |
| 2012 Q2 | 3.95 Billion GBP | -1.22% |
| 2012 Q1 | 4 Billion GBP | 3.49% |
| 2011 Q2 | 4.27 Billion GBP | 5.85% |
| 2011 Q1 | 4.03 Billion GBP | 5.16% |
| 2011 FY | 3.87 Billion GBP | 0.94% |
| 2011 Q4 | 3.87 Billion GBP | -4.01% |
| 2011 Q3 | 4.03 Billion GBP | -5.53% |
| 2010 Q4 | 3.83 Billion GBP | -5.82% |
| 2010 Q1 | 4.15 Billion GBP | 2.29% |
| 2010 FY | 3.83 Billion GBP | -5.59% |
| 2010 Q3 | 4.07 Billion GBP | 0.1% |
| 2010 Q2 | 4.07 Billion GBP | -2.09% |
| 2009 FY | 4.06 Billion GBP | 0.2% |
| 2009 Q4 | 4.06 Billion GBP | -3.08% |
| 2009 Q1 | 4.1 Billion GBP | 1.26% |
| 2009 Q2 | 3.91 Billion GBP | -4.8% |
| 2009 Q3 | 4.19 Billion GBP | 7.24% |
| 2008 Q1 | 3.31 Billion GBP | 8.13% |
| 2008 Q3 | 3.51 Billion GBP | -0.28% |
| 2008 Q4 | 4.05 Billion GBP | 15.39% |
| 2008 FY | 4.05 Billion GBP | 32.46% |
| 2008 Q2 | 3.52 Billion GBP | 6.37% |
| 2007 Q3 | 2.96 Billion GBP | 7.51% |
| 2007 Q2 | 2.75 Billion GBP | 7.99% |
| 2007 Q1 | 2.55 Billion GBP | 4.84% |
| 2007 Q4 | 3.06 Billion GBP | 3.37% |
| 2007 FY | 3.06 Billion GBP | 25.65% |
| 2006 Q4 | 2.43 Billion GBP | -2.28% |
| 2006 Q2 | 2.4 Billion GBP | 2.39% |
| 2006 FY | 2.43 Billion GBP | 11.94% |
| 2006 Q3 | 2.49 Billion GBP | 3.75% |
| 2006 Q1 | 2.34 Billion GBP | 7.84% |
| 2005 FY | 2.17 Billion GBP | -0.73% |
| 2005 Q1 | 2.13 Billion GBP | -2.8% |
| 2005 Q2 | 2.16 Billion GBP | 1.78% |
| 2005 Q3 | 2.2 Billion GBP | 1.48% |
| 2005 Q4 | 2.17 Billion GBP | -1.07% |
| 2004 Q3 | 2.26 Billion GBP | 6.14% |
| 2004 FY | 2.19 Billion GBP | 3.98% |
| 2004 Q4 | 2.19 Billion GBP | -3.21% |
| 2004 Q2 | 2.13 Billion GBP | 1.09% |
| 2004 Q1 | 2.11 Billion GBP | 0.18% |
| 2003 Q1 | 2.16 Billion GBP | 3.88% |
| 2003 FY | 2.1 Billion GBP | 1.39% |
| 2003 Q4 | 2.1 Billion GBP | -6.43% |
| 2003 Q3 | 2.25 Billion GBP | 1.31% |
| 2003 Q2 | 2.22 Billion GBP | 2.84% |
| 2002 Q2 | 2.19 Billion GBP | 2.19% |
| 2002 Q3 | 2.16 Billion GBP | -1.19% |
| 2002 FY | 2.08 Billion GBP | -0.68% |
| 2002 Q4 | 2.08 Billion GBP | -3.93% |
| 2002 Q1 | 2.14 Billion GBP | 2.37% |
| 2001 FY | 2.09 Billion GBP | -8.02% |
| 2001 Q4 | 2.09 Billion GBP | -7.37% |
| 2001 Q3 | 2.26 Billion GBP | -2.71% |
| 2001 Q2 | 2.32 Billion GBP | -3.17% |
| 2001 Q1 | 2.4 Billion GBP | 5.4% |
| 2000 FY | 2.27 Billion GBP | 48.15% |
| 2000 Q3 | 2.33 Billion GBP | -0.51% |
| 2000 Q2 | 2.34 Billion GBP | 1.69% |
| 2000 Q1 | 2.3 Billion GBP | 50.03% |
| 2000 Q4 | 2.27 Billion GBP | -2.4% |
| 1999 FY | 1.53 Billion GBP | 33.19% |
| 1999 Q4 | 1.53 Billion GBP | 0.0% |
| 1999 Q2 | 1.4 Billion GBP | 0.0% |
| 1998 Q4 | 1.15 Billion GBP | 0.0% |
| 1998 FY | 1.15 Billion GBP | 34.97% |
| 1998 Q2 | 947.58 Million GBP | 0.0% |
| 1997 FY | 855 Million GBP | 6.34% |
| 1997 Q4 | 855 Million GBP | 0.0% |
| 1996 Q4 | 804 Million GBP | 0.0% |
| 1996 FY | 804 Million GBP | -0.86% |
| 1995 Q2 | 757.92 Million GBP | 0.0% |
| 1995 FY | 811 Million GBP | 41.04% |
| 1994 Q2 | 575 Million GBP | 0.0% |
| 1994 FY | 575 Million GBP | -3.36% |
| 1993 Q2 | 595 Million GBP | 0.0% |
| 1993 FY | 595 Million GBP | 25.26% |
| 1992 FY | 475 Million GBP | -3.85% |
| 1992 Q2 | 475 Million GBP | 0.0% |
| 1991 FY | 494 Million GBP | 18.47% |
| 1991 Q2 | 494 Million GBP | 0.0% |
| 1990 Q2 | 417 Million GBP | 0.0% |
| 1990 FY | 417 Million GBP | 18.8% |
| 1989 Q2 | 351 Million GBP | 0.0% |
| 1989 FY | 351 Million GBP | 13.23% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AstraZeneca PLC | 5.41 Billion USD | -1.508% |
| Bristol-Myers Squibb Company PFD CONV 2 | 2.66 Billion USD | -106.536% |
| CSPC Pharmaceutical Group Limited | 442.43 Million USD | -1142.678% |
| Clarus Therapeutics Holdings, Inc. | 14.21 Million USD | -38580.174% |
| Novartis AG | 5.91 Billion USD | 7.018% |
| PT Kalbe Farma Tbk. | 451.27 Million USD | -1118.313% |